Related Experiment Video
Updated: Nov 22, 2025
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
Nanocarrier vaccines for SARS-CoV-2.
Jatin Machhi1, Farah Shahjin1, Srijanee Das2
1Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, NE 68198, USA.
The COVID-19 pandemic requires effective vaccines. Nanocarrier delivery systems are crucial for developing advanced vaccines to control the spread of SARS-CoV-2 and end the global health crisis.
Area of Science:
- Virology
- Immunology
- Nanotechnology
Background:
- The SARS-CoV-2 pandemic has caused widespread illness, death, and societal disruption.
- Current treatments for COVID-19 primarily focus on managing symptoms and acute respiratory distress syndrome, with no definitive cures available.
Purpose of the Study:
- To summarize recent developments in SARS-CoV-2 vaccines.
- To highlight the significant role of nanocarrier delivery systems in vaccine advancements.
Main Methods:
- Review of scientific literature on SARS-CoV-2 vaccines.
- Analysis of the application of nanocarrier technology in vaccine development.
Main Results:
- Vaccines represent the most promising strategy for controlling the pandemic.
- Nanocarrier delivery systems have been instrumental in the development and efficacy of novel vaccines.
Conclusions:
- Continued development and deployment of vaccines are essential for global pandemic control.
- Nanocarrier technology plays a pivotal role in enhancing vaccine effectiveness against SARS-CoV-2.
More Related Videos
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
